Portal de Periódicos da CAPES

Cognitive Impairment Is a Common Comorbidity in Deceased COVID-19 Patients: A Hospital-Based Retrospective Cohort Study

2020; IOS Press; Volume: 78; Issue: 4 Linguagem: Inglês

10.3233/jad-200937

1875-8908

Paloma Martín‐Jiménez, Mariana I. Muñoz-García, David Seoane, Lucas Roca-Rodríguez, Ana García‐Reyne, Antonio Lalueza, Guillermo Maestro de la Calle, Dolores Folgueira, Víctor Antonio Blanco-Palmero, Alejandro Herrero-San Martín, Sara Llamas‐Velasco, David A. Pérez-Martínez, Marta González‐Sánchez, Alberto Villarejo‐Galende,

Dementia and Cognitive Impairment Research

We analyzed the frequency of cognitive impairment (CI) in deceased COVID-19 patients at a tertiary hospital in Spain. Among the 477 adult cases who died after admission from March 1 to March 31, 2020, 281 had confirmed COVID-19. CI (21.1% dementia and 8.9% mild cognitive impairment) was a common comorbidity. Subjects with CI were older, tended to live in nursing homes, had shorter time from symptom onset to death, and were rarely admitted to the ICU, receiving palliative care more often. CI is a frequent comorbidity in deceased COVID-19 subjects and is associated with differences in care.